141 related articles for article (PubMed ID: 22616667)
1. Drug-drug interactions involving lysosomes: mechanisms and potential clinical implications.
Logan R; Funk RS; Axcell E; Krise JP
Expert Opin Drug Metab Toxicol; 2012 Aug; 8(8):943-58. PubMed ID: 22616667
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the roles of autophagy and lysosomal trafficking defects in intracellular distribution-based drug-drug interactions involving lysosomes.
Logan R; Kong A; Krise JP
J Pharm Sci; 2013 Nov; 102(11):4173-80. PubMed ID: 23970383
[TBL] [Abstract][Full Text] [Related]
3. Cationic amphiphilic drugs cause a marked expansion of apparent lysosomal volume: implications for an intracellular distribution-based drug interaction.
Funk RS; Krise JP
Mol Pharm; 2012 May; 9(5):1384-95. PubMed ID: 22449202
[TBL] [Abstract][Full Text] [Related]
4. Time-dependent effects of hydrophobic amine-containing drugs on lysosome structure and biogenesis in cultured human fibroblasts.
Logan R; Kong AC; Krise JP
J Pharm Sci; 2014 Oct; 103(10):3287-96. PubMed ID: 25042198
[TBL] [Abstract][Full Text] [Related]
5. Interactions between promazine and antidepressants at the level of cellular distribution.
Daniel WA; Wójcikowski J
Pharmacol Toxicol; 1997 Dec; 81(6):259-64. PubMed ID: 9444666
[TBL] [Abstract][Full Text] [Related]
6. A novel assay reveals that weakly basic model compounds concentrate in lysosomes to an extent greater than pH-partitioning theory would predict.
Duvvuri M; Krise JP
Mol Pharm; 2005; 2(6):440-8. PubMed ID: 16323951
[TBL] [Abstract][Full Text] [Related]
7. The effects of high physical activity on pharmacokinetic drug interactions.
Lenz TL
Expert Opin Drug Metab Toxicol; 2011 Mar; 7(3):257-66. PubMed ID: 21244343
[TBL] [Abstract][Full Text] [Related]
8. Amine-containing molecules and the induction of an expanded lysosomal volume phenotype: a structure-activity relationship study.
Logan R; Kong AC; Axcell E; Krise JP
J Pharm Sci; 2014 May; 103(5):1572-80. PubMed ID: 24647827
[TBL] [Abstract][Full Text] [Related]
9. Quantitation of Lysosomal Trapping of Basic Lipophilic Compounds Using In Vitro Assays and In Silico Predictions Based on the Determination of the Full pH Profile of the Endo-/Lysosomal System in Rat Hepatocytes.
Schmitt MV; Lienau P; Fricker G; Reichel A
Drug Metab Dispos; 2019 Jan; 47(1):49-57. PubMed ID: 30409837
[TBL] [Abstract][Full Text] [Related]
10. Extension of the Mechanistic Tissue Distribution Model of Rodgers and Rowland by Systematic Incorporation of Lysosomal Trapping: Impact on Unbound Partition Coefficient and Volume of Distribution Predictions in the Rat.
Schmitt MV; Reichel A; Liu X; Fricker G; Lienau P
Drug Metab Dispos; 2021 Jan; 49(1):53-61. PubMed ID: 33148688
[TBL] [Abstract][Full Text] [Related]
11. Altered disposition of drugs in acute renal failure rat models: drug development strategies and perspectives.
Srinivas NR
Arzneimittelforschung; 2010; 60(12):731-48. PubMed ID: 21265465
[TBL] [Abstract][Full Text] [Related]
12. Optimizing the in vitro and clinical assessment of drug interaction risk by understanding co-medications in patient populations.
Bloomer J; Derimanov G; Dumont E; Ellens H; Matheny C
Expert Opin Drug Metab Toxicol; 2013 Jun; 9(6):737-51. PubMed ID: 23586918
[TBL] [Abstract][Full Text] [Related]
13. Incorporation of lysosomal sequestration in the mechanistic model for prediction of tissue distribution of basic drugs.
Assmus F; Houston JB; Galetin A
Eur J Pharm Sci; 2017 Nov; 109():419-430. PubMed ID: 28823852
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of cellular distribution of psychotropic drugs. Significance for drug action and interactions.
Daniel WA
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):65-73. PubMed ID: 12551728
[TBL] [Abstract][Full Text] [Related]
15. In Vitro and in Silico Tools To Assess Extent of Cellular Uptake and Lysosomal Sequestration of Respiratory Drugs in Human Alveolar Macrophages.
Ufuk A; Assmus F; Francis L; Plumb J; Damian V; Gertz M; Houston JB; Galetin A
Mol Pharm; 2017 Apr; 14(4):1033-1046. PubMed ID: 28252969
[TBL] [Abstract][Full Text] [Related]
16. Effect of alpha-1-acid glycoprotein binding on pharmacokinetics and pharmacodynamics.
Huang Z; Ung T
Curr Drug Metab; 2013 Feb; 14(2):226-38. PubMed ID: 23092311
[TBL] [Abstract][Full Text] [Related]
17. The role of lysosomes in limiting drug toxicity in mice.
Ndolo RA; Forrest ML; Krise JP
J Pharmacol Exp Ther; 2010 Apr; 333(1):120-8. PubMed ID: 20056778
[TBL] [Abstract][Full Text] [Related]
18. Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability - considerations for drug development.
Lai Y; Varma M; Feng B; Stephens JC; Kimoto E; El-Kattan A; Ichikawa K; Kikkawa H; Ono C; Suzuki A; Suzuki M; Yamamoto Y; Tremaine L
Expert Opin Drug Metab Toxicol; 2012 Jun; 8(6):723-43. PubMed ID: 22509796
[TBL] [Abstract][Full Text] [Related]
19. Identification of lysosomotropic compounds based on the distribution and size of lysosomes.
Seo I; Jha BK; Lim JG; Suh SI; Suh MH; Baek WK
Biochem Biophys Res Commun; 2014 Jul; 450(1):189-94. PubMed ID: 24878535
[TBL] [Abstract][Full Text] [Related]
20. Uptake of imipramine in rat liver lysosomes in vitro and its inhibition by basic drugs.
Ishizaki J; Yokogawa K; Ichimura F; Ohkuma S
J Pharmacol Exp Ther; 2000 Sep; 294(3):1088-98. PubMed ID: 10945864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
